Creative Biolabs: Vaccine Solutions Exclusively for Monkeypox Pandemic!

United States – August 11, 2022 /MarketersMEDIA/ —

While it is clinically less severe than smallpox, the monkeypox virus (MPV) is a viral zoonosis (a virus that spreads from animal to human) causing symptoms that are comparable to those of smallpox. In May 2022, multiple monkeypox cases were identified in several non-endemic countries, which raised the alarm in global health communities and encouraged further study of its spread chains and effective prevention. Creative Biolabs, as an expert in vaccine design against diverse pathogens—especially viruses, responded immediately with leveraged resources and allocated a team of specialists serving exclusively for researchers exploring vaccines against monkeypox viruses.

“Smallpox vaccines, to some extent, may have preventive effects against monkeypox,” according to a specialist at Creative Biolabs who works exclusively on vaccines against viral pathogens, “yet as smallpox was already eliminated in the 1980s, no vaccinations against smallpox have been conducted ever since. Hence, developing the monkeypox virus vaccine is a pressing matter at the moment.”

New Research-Use Products for Monkeypox Virus

Detection Kit: for accurate lab-based MPV detection.

• MPV Real Time PCR Kit: used for the detection of MPV DNA in whole blood, serum, plasma, or rash exudate.
• MPV Antigen ELISA Kit: used in ELISA assay to qualitatively analyze MPV antigen in whole blood, serum, plasma, or rash exudate.
• MPV IgG ELISA Kit: used in ELISA assay to qualitatively analyze MPV IgG in whole blood, serum, plasma, or rash exudate.

Recombinant Protein: used as viral antigens in ELISA, WB, SDS-PAGE assays, etc.

• Recombinant Monkeypox L1R Protein (aa 1-152) [His], Recombinant Monkeypox A29 Protein (aa 21-110) [His]

Antibody: generated by hybridoma technology to support MPV studies and used in ELISA, IF, SPR, and WB assays; offered in different sizes.

• Anti-monkeypox Virus Monoclonal Antibody (VACV-5C7), Mouse IgG1, Kappa
• Anti-monkeypox Virus Monoclonal Antibody (VACV-5C7), Human IgG1, Kappa
• Anti-monkeypox Virus Monoclonal Antibody (VACV-5C7), Human IgG1, Fc Silent, Kappa

“We’re keeping pace with the latest pandemic situation and will continue expanding our product portfolio,” added the scientist, “to meet increasing demands on research tools. We can also design and prepare diverse monkeypox vaccines to contextualize your concepts and validate them using our thorough immunological evaluation methods.”

Visit https://www.creative-biolabs.com/vaccine/ to learn more about Creative Biolabs vaccine solutions.

About

Creative Biolabs, holding profound knowledge and practical experience in immunology subjects, provides one-of-a-kind solutions for innovative vaccine R&D, including tumor vaccines, offering not only essential products such as antigens, adjuvants, and antibodies for vaccine development but also helping design vaccine candidates with greater safety and potency.

Contact Info:
Name: Candy Swift
Email: Send Email
Organization: Creative Biolabs
Website: https://www.creative-biolabs.com/vaccine/

Release ID: 89079884

If you detect any issues, problems, or errors in this press release content, kindly contact error@releasecontact.com to notify us. We will respond and rectify the situation in the next 8 hours.